Episode
How Private Equity Is Buying Up Pediatric Therapy Clinics
- Published
- Jun 28, 2026
- Duration seconds
- 507
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-buyout-show-with-fexingo-private-equity-roll-ups-and-business-acquisitions-7871630/episodes/how-private-equity-is-buying-up-pediatric-therapy-clinics/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-buyout-show-with-fexingo-private-equity-roll-ups-and-business-acquisitions-7871630/how-private-equity-is-buying-up-pediatric-therapy-clinics.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Private equity has quietly consolidated autism therapy, speech therapy, and occupational therapy practices across the US. This episode drills into the roll-up strategy behind pediatric therapy clinics — specifically the $2.8 billion acquisition of BlueSprig Pediatrics by KKR in 2021 and the subsequent platform-building that followed. Lucas explains the reimbursement dynamics (Medicaid vs. commercial insurance), the shortage of board-certified behavior analysts, and why PE firms see 20% EBITDA margins in a fragmented service market. Luna questions whether the model can sustain quality care when therapists are salaried and caseload targets rise. We also look at what happens when a roll-up hits saturation in a single metro area — using Houston as a case study. #PrivateEquity #PediatricTherapy #BlueSprig #KKR #AutismTherapy #RollUp #HealthcareInvesting #ABATherapy #BehavioralHealth #Medicaid #EBITDAMargins #Consolidation #SpeechTherapy #OccupationalTherapy #Business #Healthcare #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo